Literature DB >> 31530712

Calcium-induced dissociation of CIB1 from ASK1 regulates agonist-induced activation of the p38 MAPK pathway in platelets.

Pravin Patel1, Meghna U Naik1, Kalyan Golla1, Noor F Shaik1, Ulhas P Naik1.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase (MAPKKK) that regulates activation of the c-Jun N-terminal kinase (JNK)- and p38-stress response pathways leading to apoptosis in nucleated cells. We have previously shown that ASK1 is expressed in platelets and regulates agonist-induced platelet activation and thrombosis. However, the mechanism by which platelet agonists cause activation of ASK1 is unknown. Here, we show that in platelets agonist-induced activation of p38 is exclusively dependent on ASK1. Both thrombin and collagen were able to activate ASK1/p38. Activation of ASK1/p38 was strongly dependent on thromboxane A2 (TxA2) and ADP. Agonist-induced ASK1 activation is blocked by inhibition of phospholipase C (PLC) β/γ activity or by chelating intracellular Ca2+. Furthermore, treatment of platelets with thapsigargin or Ca2+ ionophore robustly induced ASK1/p38 activation. In addition, calcium and integrin-binding protein 1 (CIB1), a Ca2+-dependent negative regulator of ASK1, associates with ASK1 in resting platelets and is dissociated upon platelet activation by thrombin. Dissociation of CIB1 corresponds with ASK1 binding to tumor necrosis factor (TNF) receptor associated factor 6 (TRAF6) and the autophosphorylation of ASK1 Thr838 within the catalytic domain results in full activation of ASK1. Furthermore, genetic ablation of Cib1 in mice augments agonist-induced Ask1/p38 activation. Together our results suggest that in resting platelets ASK1 is bound to CIB1 at low Ca2+ concentrations. Agonist-induced platelet activation causes an increase in intracellular Ca2+ concentration that leads to the dissociation of CIB1 from ASK1, allowing for proper dimerization through ASK1 N-terminal coiled-coil (NCC) domains.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  ASK1; CIB1; calcium; p38; platelet adhesion and activation; reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31530712      PMCID: PMC7071732          DOI: 10.1042/BCJ20190410

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain.

Authors:  U P Naik; P M Patel; L V Parise
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 2.  The regulatory and signaling mechanisms of the ASK family.

Authors:  Takuto Nishida; Kazuki Hattori; Kengo Watanabe
Journal:  Adv Biol Regul       Date:  2017-05-22

3.  Platelet JNK1 is involved in secretion and thrombus formation.

Authors:  Frédéric Adam; Alexandre Kauskot; Paquita Nurden; Eric Sulpice; Marc F Hoylaerts; Roger J Davis; Jean-Philippe Rosa; Marijke Bryckaert
Journal:  Blood       Date:  2010-03-15       Impact factor: 22.113

4.  Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.

Authors:  H Enslen; J Raingeaud; R J Davis
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer.

Authors:  Kei Tobiume; Masao Saitoh; Hidenori Ichijo
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

6.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

7.  Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.

Authors:  Katsue Suzuki-Inoue; Osamu Inoue; Jon Frampton; Steve P Watson
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

8.  Mechanism of p38 MAP kinase activation in vivo.

Authors:  Deborah Brancho; Nobuyuki Tanaka; Anja Jaeschke; Juan-Jose Ventura; Nyaya Kelkar; Yoshinori Tanaka; Masanao Kyuuma; Toshikazu Takeshita; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

Review 9.  Calcium signaling in platelets.

Authors:  D Varga-Szabo; A Braun; B Nieswandt
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

10.  CaMKII activates ASK1 to induce apoptosis of spinal astrocytes under oxygen-glucose deprivation.

Authors:  Gang Liu; Jianning Zhao; Zhiyong Chang; Guodong Guo
Journal:  Cell Mol Neurobiol       Date:  2013-03-16       Impact factor: 5.046

View more
  4 in total

1.  Positive regulation of TNFR1 signaling via SH3 recognition motif.

Authors:  Fatma Ece Çopuroğlu; Fatma Zehra Hapil; Şükran Burçak Yoldaş; Osman Nidai Özeş
Journal:  Turk J Biol       Date:  2021-04-20

2.  Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway.

Authors:  Bin-Bin Zhang; Lu Gao; Qin Yang; Yuan Liu; Xiao-Yue Yu; Ji-Hong Shen; Wen-Cai Zhang; Zhan-Ying Han; Shao-Ze Chen; Sen Guo
Journal:  Cell Death Dis       Date:  2021-10-22       Impact factor: 8.469

3.  Apoptosis signal-regulating kinase 1 regulates immune-mediated thrombocytopenia, thrombosis, and systemic shock.

Authors:  Pravin Patel; Noor F Shaik; Yuhang Zhou; Kalyan Golla; Steven E McKenzie; Ulhas P Naik
Journal:  J Thromb Haemost       Date:  2020-09-09       Impact factor: 5.824

4.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.